Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1/2 2

Status

Terminated 2Unknown 1Completed 1

Sponsor Class

INDUSTRY 29OTHER 4NIH 3

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 7Other hematologic neoplasm 4

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, B-Cell 1Leukemia 1

Interventions

Cyclophosphamide 678Cytarabine 576fludarabine 410fludarabine phosphate 387venetoclax 310Methotrexate 297Rituximab 283Azacitidine 264Busulfan 248Whole-Body Irradiation 220Etoposide 215Filgrastim 214Peripheral Blood Stem Cell Transplantation 211Mycophenolic Acid 206Tacrolimus 196Dexamethasone 191Granulocyte Colony-Stimulating Factor 182Vincristine 173Melphalan 173Decitabine 163Cyclosporine 146Daunorubicin 139Antilymphocyte Serum 137Idarubicin 134Imatinib Mesylate 127Lenalidomide 116Doxorubicin 109Radiotherapy 108Stem Cell Transplantation 107Clofarabine 106

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Chlorambucil × Other hematologic neoplasm × Clear all
NCT00558961 2023-03-27

GL-CLB-001

Jewish General Hospital

Phase 1/2 Terminated
13 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00262795 2019-05-23

Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

German CLL Study Group

Phase 3 Completed
206 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01403246 2019-02-12

Chlorambucil + Lenalidomide and Lenalidomide Maintenance in Untreated Elderly With Chronic Lymphocytic Leukemia (CLL)

Gruppo Italiano Malattie EMatologiche dell'Adulto

Phase 1/2 Terminated
9 enrolled 5 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01678430 2012-10-15

RIAltO

University of Liverpool

Phase 3 Unknown
670 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡